Interleukin-18 concentration in the peritoneal fluid correlates with the severity of peritonitis

American Journal of Surgery

Volumn 185, Issue 6, 2003, Pages 550-555

  Ikuta, Shin Ichi ^a   Ono, Satoshi ^a   Kinoshita, Manabu ^a   Tsujimoto, Hironori ^a   Yamauchi, Akira ^a   Mochizuki, Hidetaka ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Interferon gamma; Interleukin 10; Interleukin 18; Peritonitis; Th1 cytokine; Th2 cytokine

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 18;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HOSPITALIZATION; HUMAN; INFLAMMATION; LAPAROTOMY; MALE; PERITONEAL FLUID; PERITONITIS; PRIORITY JOURNAL;

EID: 0038697371     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(03)00080-1     Document Type: Article

References (36)

1. Scheuerlein H., Kube R., Gastinger I., Kockerling F. Prospective multicenter comparative study of the management of peritonitis. Quality assurance in severe intra-abdominal infection. Zentralbl Chir. 125:2000;199-204.
2. Giroir B.P. Mediators of septic shock new approaches for interrupting the endogenous inflammatory cascade . Crit Care Med. 21:1993;780-789.
3. Fugger R., Zadrobilek E., Gotzinger P., et al. Perioperative TNF alpha and IL-6 concentrations correlate with septic state, organ function, and APACHE II scores in intra-abdominal infection. Eur J Surg. 159:1993;525-529.
4. Patel R.T., Deen K.I., Youngs D., et al. Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg. 81:1994;1306-1308.
5. Riche F.C., Cholley B.P., Panis Y.H., et al. Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis. Crit Care Med. 28:2000;433-437.
6. Bagby G.J., Plessala K.J., Wilson L.A., et al. Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis. J Infect Dis. 163:1991;83-88.
7. McMasters K.M., Cheadle W.G. Regulation of macrophage TNF alpha, IL-1 beta, and Ia (I-A alpha) mRNA expression during peritonitis is site dependent. J Surg Res. 54:1993;426-430.
8. Zeni F., Tardy B., Vindimian M., et al. High levels of tumor necrosis factor-alpha and interleukin-6 in the ascitic fluid of cirrhotic patients with spontaneous bacterial peritonitis. Clin Infect Dis. 17:1993;218-223.
9. Propst T., Propst A., Herold M., et al. Spontaneous bacterial peritonitis is associated with high levels of interleukin-6 and its secondary mediators in ascitic fluid. Eur J Clin Invest. 23:1993;832-836.
10. Zemel D., Krediet R.T., Koomen G.C., et al. Interleukin-8 during peritonitis in patients treated with CAPD an in-vivo model of acute inflammation . Nephrol Dial Transplant. 9:1994;169-174.
11. Nakahama H., Tanaka Y., Shirai D., et al. Plasma interleukin-6 levels in continuous ambulatory peritoneal dialysis and hemodialysis patients. Nephron. 61:1992;132-134.
12. Okamura H., Tsutsui H., Kashiwamura S., et al. Interleukin-18 a novel cytokine that augments both innate and acquired immunity . Adv Immunol. 70:1998;281-312.
13. Dinarello C.A. Interleukin-18 a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family . J Allergy Clin Immunol. 103:1999;11-24.
14. Rau B., Baumgart K., Paszkowski A.S., et al. Clinical relevance of caspase-1 activated cytokines in acute pancreatitis high correlation of serum interleukin-18 with pancreatic necrosis and systemic complications . Crit Care Med. 29:2001;1556-1562.
15. Fujimori Y., Takatsuka H., Takemoto Y., et al. Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol. 109:2000;652-657.
16. Takada H., Nomura A., Ohga S., Hara T. Interleukin-18 in hemophagocytic lymphohistiocytosis. Leuk Lymphoma. 42:2001;21-28.
17. Yamada G., Shijubo N., Shigehara K., et al. Increased levels of circulating interleukin-18 in patients with advanced tuberculosis. Am J Respir Crit Care Med. 161:2000;1786-1789.
18. Kawabata T., Ichikura T., Majima T., et al. Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma. Cancer. 92:2001;2050-2055.
19. Endo S., Inada K., Yamada Y., et al. Interleukin-18 (IL-18) levels in patients with sepsis. J Med. 31:2000;15-20.
20. Grobmyer S.R., Lin E., Lowry S.F., et al. Elevation of IL-18 in human sepsis. J Clin Immunol. 20:2000;212-215.
21. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II a severity of disease classification system . Crit Care Med. 13:1985;818-829.
22. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 20:1992;864-874.
23. Goris R.J., Boekhorst T.P., Nuytinck J.K., Gimbrere J.S. Multiple-organ failure generalized autodestructive inflammation? Arch Surg. 120:1985;1109-1115.
24. Sakao Y., Takeda K., Tsutsui H., et al. Interleukin-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock. Int Immunol. 11:1999;471-480.
25. Mastroeni P., Clare S., Khan S., et al. Interleukin-18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect Immun. 67:1999;478-483.
26. Bohn E., Sing A., Zumbihl R., et al. Interleukin-18 (IFN-γ-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol. 160:1998;299-307.
27. Kawakami K., Qureshi M.H., Zhang T., et al. Interleukin-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-γ production. J Immunol. 159:1997;5528-5534.
28. Schein M., Wittmann D.H., Holzheimer R., Condon R.E. Hypothesis compartmentalization of cytokines in intraabdominal infection . Surgery. 119:1996;694-699.
29. Decker D., Schöndorf M., Bidlingmaier F., et al. Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery. 119:1996;316-325.
30. Lin E., Calvano S.E., Lowry S.F. Inflammatory cytokines and cell response in surgery. Surgery. 127:2000;117-126.
31. Moss N.M., Gough D.B., Jordan A.L., et al. Temporal correlation of impaired immune response after thermal injury with susceptibility to infection in a murine model. Surgery. 104:1988;882-887.
32. Wood J.J., Rodrick M.L., O'Mahony J.B., Mannick J.A. Inadequate interleukin 2 production a fundamental immunological deficiency in patients with major burns . Ann Surg. 200:1984;311-320.
33. O'Sullivan S.T., Lederer J.A., Horgan A.F., et al. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg. 222:1995;482-492.
34. Ono S., Ueno C., Aosasa S., et al. Severe sepsis induces deficient interferon-gamma and interleukin-12 production, but interleukin-12 therapy improves survival in peritonitis. Am J Surg. 182:2001;491-497.
35. Dipiro J.T., Howdieshell T.R., Goddard J.K., et al. Association of interleukin-4 plasma levels with traumatic injury and clinical course. Arch Surg. 130:1995;1159-1163.
36. Yoshimoto T., Mizutani H., Tsutsui H., et al. Interleukin-18 induction of IgE dependence on CD4+T cells, IL-4 n STAT6 . Nature Immunol. 2:2000;132.